Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

被引:52
|
作者
Mateo, Lourdes [1 ]
Holgado, Susana [1 ]
Marinoso, Maria Luisa [2 ]
Perez-Andres, Ricard [3 ]
Bonjoch, Anna [4 ,5 ]
Romeu, Joan [5 ]
Olive, Alejandro [1 ]
机构
[1] Univ Hosp Germans Trias & Pujol, Rheumatol Serv, Carretera Canyet S-N, Barcelona 08916, Spain
[2] Hosp del Mar, Pathol Serv, Barcelona, Spain
[3] Univ Hosp Germans Trias & Pujol, Serv Radiol, Carretera Canyet S-N, Barcelona 08916, Spain
[4] Univ Hosp Germans Trias & Pujol, Lluita SIDA Fdn, Carretera Canyet S-N, Barcelona 08916, Spain
[5] Univ Hosp Germans Trias & Pujol, Dept Internal Med, Carretera Canyet S-N, Barcelona 08916, Spain
关键词
Fanconi syndrome; HIV; Hypophosphatemic osteomalacia; Osteomalacia; Proximal renal tubulopathy; Tenofovir; RENAL TUBULAR DYSFUNCTION; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; FANCONI SYNDROME; FRACTURES; THERAPY; SAFETY; COMBINATION; PREVALENCE; FAILURE;
D O I
10.1007/s10067-014-2627-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tenofovir disoproxil fumarate (TDF) is an adenine analogue reverse transcription inhibitor widely used in first-line treatment of human immunodeficiency virus (HIV) infection and also in hepatitis B virus infection. Its use has been linked to sporadic Fanconi syndrome, renal failure and bone disease. We present the clinical characteristics of tenofovir-induced osteomalacia, discuss bone biopsy findings, describe predisposing factors and compare our results with other reported cases. We describe five cases of hypophosphatemic osteomalacia induced by TDF and recorded at the rheumatology service of a university hospital between 2010 and 2014. We also report the characteristics of bone biopsies of this pathology, which have not been previously described. We include a review of published cases of proximal renal tubulopathy (PRT) and osteomalacia induced by TDF (PubMed 1995-2014; keywords: osteomalacia, tenofovir, Fanconi syndrome, hypophosphatemic osteomalacia, proximal renal tubulopathy, bone biopsy). Five HIV patients who developed hypophosphatemic osteomalacia under TDF treatment (> 5 years) presented increasing bone pain and a progressive inability to walk without assistance as a result of multiple insufficiency fractures. Bone biopsy performed in three patients after tetracycline labelling showed increased osteoid thickness, confirming osteomalacia. A literature review retrieved 17 publications on this condition, including 53 cases: 26 patients developed isolated PRT, 25 presented PRT and with multiple insufficiency fractures and two presented isolated bone disease, including osteomalacia and osteoporosis. Rheumatologists should be alert to this complication in patients receiving tenofovir. The main complaint reported by these patients is diffuse pain, predominantly in the lower limbs, indicating multiple stress fractures. Serum phosphate and appropriate screening for abnormal proximal tubule function should be monitored. Bone scintigraphy should be carried out in cases of limb pain before the occurrence of more severe complications.
引用
收藏
页码:1271 / 1279
页数:9
相关论文
共 50 条
  • [21] Incapacitating pain from Tenofovir Induced Hypophosphatemic Osteomalacia in a Hemophilia Patient - A Case Report
    Woo, Emma
    Kumbhare, Dinesh
    Winston, Paul
    CANADIAN JOURNAL OF PAIN-REVUE CANADIENNE DE LA DOULEUR, 2020, 4 (01): : 287 - 291
  • [22] Clinical management of hypophosphatemic osteomalacia induced by adefovir and tenofovir: Insights from a case report
    He, Yinhui
    Huang, Xin
    Ye, Yongjun
    Xu, Haiyan
    MEDICINE, 2024, 103 (48)
  • [23] Clinical Images: Tenofovir-Induced Fanconi Syndrome: An Uncommon Cause of Hypophosphatemic Osteomalacia
    Sahoo, Rasmi Ranjan
    Wakhlu, Anupam
    ACR OPEN RHEUMATOLOGY, 2022, 4 (06) : 484 - 485
  • [24] Adefovir induced hypophosphatemic osteomalacia
    Fabbriciani, Gianluigi
    De Socio, Giuseppe Vittorio L.
    Massarotti, Marco
    Ceriani, Roberto
    Marasini, Bianca
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (11-12) : 990 - 992
  • [25] Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use
    Rao, Mana
    Dadey, Liam
    Glowa, Thomas
    Veldkamp, Peter
    INFECTIOUS DISEASE REPORTS, 2021, 13 (02) : 448 - 453
  • [26] Tenofovir plasma concentrations in obese and normal weight HIV-infected patients.
    Foster, Rachel
    Derrick, Caroline
    Rampaul, Marlon
    Cottrell, Mackenzie
    Cuteri, Angelena
    Bookstaver, P. Brandon
    Caulder, Celeste
    Weissman, Sharon
    Aninyei, Isioma
    Justo, Julie Ann
    PHARMACOTHERAPY, 2017, 37 (06): : E56 - E57
  • [27] Impact of Tenofovir on Renal Function in HIV-Infected, Antiretroviral-Naive Patients
    Horberg, Michael
    Tang, Beth
    Towner, William
    Silverberg, Michael
    Bersoff-Matcha, Susan
    Hurley, Leo
    Chang, Joseph
    Blank, Jackie
    Quesenberry, Charles, Jr.
    Klein, Daniel
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (01) : 62 - 69
  • [28] Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir
    García-Benayas, T
    Rendón, AL
    Rodríguez-Novóa, S
    Barrios, A
    Maida, I
    Blanco, F
    Barreiro, P
    Rivas, P
    González-Lahoz, J
    Soriano, V
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (04) : 333 - 337
  • [29] Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword?
    Tourret, Jerome
    Deray, Gilbert
    Isnard-Bagnis, Corinne
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (10): : 1519 - 1527
  • [30] Tenofovir-associated renal toxicity in a cohort of HIV-infected patients in Ghana
    Nartey, Edmund T.
    Tetteh, Raymond A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 581 - 581